NewGenIvf Group Limited
(NIVF) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.39
0.74%
After-hours Jan 03, 2025, 05:57 PM EST
Company Description
NewGenIVF Group Ltd. operates as an assisted reproductive services provider.
It focuses on providing fertility treatments to fulfil the dreams of building families.
The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.
The company is headquartered in Bangkok, Thailand.
NewGenIvf Group Limited
Country | TH |
IPO Date | Mar 18, 2022 |
Industry | Medical - Healthcare Plans |
Sector | Healthcare |
Employees | n/a |
CEO | Wing Fung Siu |
Contact Details
Address: No Address available Bangkok, TH | |
Website | n/a |
Stock Details
Ticker Symbol | NIVF |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001981662 |
CUSIP Number | n/a |
ISIN Number | VGG0544E1051 |
Employer ID | 00-0000000 |
SIC Code | 8090 |
Key Executives
No executives data available.Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 05, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Dec 05, 2024 | F-1/A | [Amend] Filing |
Dec 03, 2024 | 6-K | Filing |
Nov 22, 2024 | F-1 | Filing |
Nov 22, 2024 | 6-K | Filing |
Nov 18, 2024 | 6-K | Filing |
Nov 15, 2024 | 6-K | Filing |
Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 13, 2024 | 3 | Filing |
Nov 08, 2024 | 424B3 | Filing |